Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP18592.RADAAvvG0M5xRpk7uTAboQFDj5igBV2a10-8GEodH2P_k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP18592.RADAAvvG0M5xRpk7uTAboQFDj5igBV2a10-8GEodH2P_k130_assertion type Assertion NP18592.RADAAvvG0M5xRpk7uTAboQFDj5igBV2a10-8GEodH2P_k130_head.
- NP18592.RADAAvvG0M5xRpk7uTAboQFDj5igBV2a10-8GEodH2P_k130_assertion wasGeneratedBy ECO_0000218 NP18592.RADAAvvG0M5xRpk7uTAboQFDj5igBV2a10-8GEodH2P_k130_provenance.
- NP18592.RADAAvvG0M5xRpk7uTAboQFDj5igBV2a10-8GEodH2P_k130_assertion wasDerivedFrom ctd_human-2016 NP18592.RADAAvvG0M5xRpk7uTAboQFDj5igBV2a10-8GEodH2P_k130_provenance.
- NP18592.RADAAvvG0M5xRpk7uTAboQFDj5igBV2a10-8GEodH2P_k130_assertion SIO_000772 17043644 NP18592.RADAAvvG0M5xRpk7uTAboQFDj5igBV2a10-8GEodH2P_k130_provenance.
- NP18592.RADAAvvG0M5xRpk7uTAboQFDj5igBV2a10-8GEodH2P_k130_assertion evidence source_evidence_curated NP18592.RADAAvvG0M5xRpk7uTAboQFDj5igBV2a10-8GEodH2P_k130_provenance.
- NP18592.RADAAvvG0M5xRpk7uTAboQFDj5igBV2a10-8GEodH2P_k130_assertion description "[Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP18592.RADAAvvG0M5xRpk7uTAboQFDj5igBV2a10-8GEodH2P_k130_provenance.